学校儿童的喘和过敏:来自欧洲SINPHONIE研究的数据
G Sarno1, S Maio1, I Stanisci1
1Pulmonary Environmental Epidemiology Unit, National Research Council (CNR), Institute of Clinical Physiology (IFC), Pisa, Italy.
概括
儿童喘和过敏在欧洲各地具有显著的地理差异. 了解这些患病率差异对于欧洲学童有效的预防策略至关重要.
科学领域:
- 环境健康 环境健康
- 儿科流行病学 儿科流行病学
- 过敏和免疫学 过敏和免疫学
背景情况:
- 喘和过敏是普遍存在的儿童慢性疾病.
- SINPHONIE项目调查了欧洲学校的室内污染和健康状况.
- 评估了儿童喘和过敏患病率的地理差异.
研究的目的:
- 确定欧洲学童中喘和过敏的患病率.
- 分析这些条件发生的地理差异.
- 识别症状和地理集群之间的潜在关联.
主要方法:
- 分析了4899名学龄儿童 (6-14岁) 的家长/监护人问卷.
- 数据收集来自23个欧洲国家的54个城市 (2011-2012).
- 用于估计调整的流行率和地理关联的物流回归模型.
主要成果:
- 西欧 (WE) 和中东欧 (CEE) 的湿疹患病率更高.
- 在西欧,中东欧和南欧 (SE) 地区观察到干燥夜间咳的几率增加.
- 与北欧相比,在欧洲各个地区发现过敏性鼻炎,物/花粉过敏和喘症状的几率较低.
结论:
- 在欧洲儿童中喘和过敏的频率存在显著的地理差异.
- 患病率的变化凸显了针对地理位置的预防措施的必要性.
- 调查结果强调了考虑到儿童呼吸系统和过敏健康的区域因素的重要性.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Asthma: Pathogenesis and Management
314
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
314
Allergic Reactions
27.2K
Overview
27.2K


